AI assistant
Sending…
Anika Therapeutics, Inc. — Director's Dealing 2014
Jan 29, 2014
33997_dirs_2014-01-29_14b9839d-3c70-431c-a0d2-8cf661577f46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2014-01-27
Reporting Person: Cheung Sylvia (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-27 | Common Stock | A | 6100 | — | Acquired | 13150 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-27 | Stock Option (Right to Buy) | $32.02 | A | 13800 | Acquired | 2024-01-27 | Common Stock (13800) | Direct |
Footnotes
F1: Restricted stock awards vest in four annual installments beginning January 27, 2015.
F2: The stock options vest in four equal installments annually beginning January 27, 2015.
More from Anika Therapeutics, Inc.
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18